Article
Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin.
British journal of haematology - 1 Jan 1996
Nakao S, Takami A, Sugimori N, Ueda M, Shiobara S, Matsuda T, Mizoguchi H
Abstract excerpt
HLA-DRB1*1501, a subtype of HLA-DR2, has been shown to be closely associated with a good response to cyclosporine (CyA) therapy in patients with aplastic anaemia (AA). To determine whether this DRB1 allele can also predict a response to antithymocyte globulin (ATG) therapy in AA patients, we analysed the results of HLA-DRB1 typing in 59 Japanese patients who received ATG within 2 years after diagnosis of AA and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.